Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bausch + Lomb Stock Pops
Why Bausch + Lomb Stock Soared by Over 7% on Monday
It was quite a busy and eventful day for the company.
Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid
Key Takeaways Bausch + Lomb shares surged Monday following reports Blackstone and TPG are considering teaming up to buy the eyecare company. A bid from Blackstone and TPG could reportedly value the company between $13 billion and $14 billion.
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
Bausch Health faces $21 billion in debt, with $10 billion due by 2027 and a $2.4 billion loan due next year. Private equity firms TPG and Blackstone are joining forces in a bid to acquire eye care company Bausch + Lomb BLCO, the Financial Times reported. Last month, Bausch + Lomb said it was considering a sale.
M&A News: TPG and Blackstone Could Eye Joint Bid for Bausch + Lomb (NYSE:BLCO)
Shares of contact lens supplier Bausch + Lomb ($BLCO) are surging in today’s trading amid news of a potential acquisition. According to an
Bausch & Lomb gains amid report TPG, Blackstone working on joint bid
Bausch & Lomb (NYSE:BLCO) jumped 9% in premarket trading on a report that private equity firms TPG (TPG) and Blackstone (BX) are working on a joint bid for the eyecare company. Several other PE shops that have been considering an offer have dropped out,
1d
Bausch Health Rejects Bondholders’ Debt Proposals, Explores Sale of Vision Care Unit
The potential sale of its 88% stake in Bausch + Lomb could generate billions for creditors and shareholders of the indebted ...
13h
Bausch Health Shares Fall after Rejecting Bondholder Proposals to Restructure Debt
Bausch Health has recently changed its strategy for Bausch + Lomb, looking to sell the segment which has a market capitalization of nearly $8 billion. The potential sale of Bausch + Lomb is a break ...
3d
Anticipated Private Equity Acquisition of Bausch + Lomb Corporation Offers Attractive Upside for Investors
In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...
ophthalmologytimes
4d
Anthony Wallace of Bausch + Lomb talks about enVista Envy FDA approval
The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.
1d
Bausch Health Companies (NYSE:BHC shareholders incur further losses as stock declines 4.4% this week, taking three-year losses to 72%
Bausch Health Companies Inc. ( NYSE:BHC ) shareholders should be happy to see the share price up 26% in the last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback